I. K. Bukholm

2.2k citations
22 papers · 1.7k indexed · h-index 19

I. K. Bukholm

22 papers receiving 1.7k citations

Peers

I. K. Bukholm
Comparison fields: 5 of 89
  • Cancer Research 462
  • Oncology 745
  • Molecular Biology 1.1k
  • Pathology and Forensic Medicine 265
  • Immunology 204
Replace Klaus‐Jürgen Winzer with:
Klaus‐Jürgen Winzer Germany
Kevin Kwei United States
M. J. Birrer United States
Hong Sug Kim South Korea
Selçuk Çolak Netherlands
Rebeca Sanz‐Pamplona Spain
Douglas W. McMillin United States
Yoke-Eng Chiew Australia
Natasha G. Deane United States
Song He China
I. K. Bukholm relative to Klaus‐Jürgen Winzer Germany Klaus‐Jürgen Winzer's profile →
Citations per field
00.5×1.5×
Klaus‐Jürgen Winzer · 1×
Citations per year

Countries citing papers authored by I. K. Bukholm

Since Specialization
Citations

This map shows the geographic impact of I. K. Bukholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. K. Bukholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. K. Bukholm more than expected).

Fields of papers citing papers by I. K. Bukholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. K. Bukholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. K. Bukholm. The network helps show where I. K. Bukholm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside I. K. Bukholm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. K. Bukholm Line = papers co-authored together I. K. Bukholm links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201359
2 201212
3 201136
4 201129
5 201143
6 2010103
7 201038
8 2009139
9 200425
10 2004338
11 2001209
12 2000187
13 199817
14 199820
15 1998160
16 199727
17 199734
18 199759
19 19976
20 199758

About I. K. Bukholm

I. K. Bukholm is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 22 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (4 papers), Genetic factors in colorectal cancer (4 papers), Cancer Cells and Metastasis (4 papers), Breast Cancer Treatment Studies (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (462 citations), Oncology (745 citations) and Molecular Biology (1.1k citations). I. K. Bukholm has collaborated with scholars based in Norway, United States and Israel. Frequent co-authors include Jahn M. Nesland, Rolf Kåresen, Anne‐Lise Børresen‐Dale, Anne-Lise B√∏rresen-Dale, Jahn M. Nesland, A.L. Børresen-Dale, Youngran Ji, Hongjuan Zhao, Stefanie S. Jeffrey and David Botstein. Their work appears in journals such as The Journal of Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, BMC Cancer, Genes Chromosomes and Cancer and Molecular Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026